United Kingdom Archives

News and Trends 16 Oct 2017

New Stem Cells Could Take Cell Research and Therapies to the Next Level

British researchers have created a new type of stem cell in mice. It has even greater potential than current cell lines in research and in the clinic. Stem cells have huge potential in research and therapeutics and overcome the limitations of current cell lines – embryonic and induced pluripotent stem cells. Findings published in Nature report that researchers at […]

October 16, 2017 - 3 minutesmins - By Alex Dale

News and Trends 12 Oct 2017

No More Seasonal Flu Shots: British Biotech’s Universal Antiviral Raises £13M

VirionHealth kicks off the development of a broad spectrum antiviral for all influenza strains and other viruses like RSV with a £13M investment in Series A. VirionHealth is developing a new type of antiviral therapy with the potential to target multiple types of viruses at once. The treatment is based on natural antivirals called defective interfering viruses. They consist […]

October 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Oct 2017

Deadly Parasite Could be Stopped by Scottish Researchers’ Discovery

A study in Scotland has improved our understanding of how a dangerous parasite functions, creating a new target for combatting deadly infections. Research from the University of Edinburgh has identified a therapeutic target in Leishmania, a parasite that infects 1 million people each year, resulting in 20,000-30,000 deaths. The study, published in the Journal of Molecular Biology, used clever […]

October 12, 2017 - 3 minutesmins - By Alex Dale

News and Trends 11 Oct 2017

Scottish Scientists Could Hold the Key to Unlocking Parkinson’s Disease

A decade of work has culminated in researchers reconstructing a protein that is key to defending the brain against Parkinson’s disease. Researchers at the University of Dundee have made a breakthrough by uncovering the 3D structure of an enzyme, PINK1, that can protect the brain against Parkinson’s disease. The disease is characterised by the degeneration […]

October 11, 2017 - 3 minutesmins - By Alex Dale

News and Trends 9 Oct 2017

British Scientists Regenerate Bone By Mimicking Nature

Nano-sized vesicles that are generated naturally during bone formation have the potential to regenerate bone, teeth and cartilage. Researchers from the University of Birmingham have mimicked the body’s natural healing process to repair damaged tissue, for example, bone. The study, which is published in Scientific Reports, has found that vesicles produced by stimulated cells outperform the […]

October 9, 2017 - 3 minutesmins - By Alex Dale

News and Trends 6 Oct 2017

Study Reveals No Evidence to Support Most European Cancer Drug Approvals

A new study concludes the majority of cancer drugs approved by the EMA between 2009 and 2013 weren’t backed by sufficient evidence that they are effective. A team of researchers from King’s College London and the London School of Economics has published a new study reviewing the clinical data used to back the approval of […]

October 6, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Oct 2017

British-Finnish Alliance to Bring Gene Therapy to the Masses

FIT Biotech and Avacta hope to combine their technologies to produce highly specific, best-in-class gene therapy treatments. The two companies have spotted an opportunity to bring together their technologies and form a leading gene therapy system in a market that could be worth over $4.3B (€3.7B) by 2024. FIT Biotech, based in Finland, has been working on […]

October 6, 2017 - 2 minutesmins - By Alex Dale

News and Trends 5 Oct 2017

British Biotech To Raise £12.2M to Finish Off Liquid Biopsy Technology

Angle will raise £12.2M, which will allow it to acquire assets from Axela to put the finishing touches to its full liquid biopsies solution. Angle is a leader in the liquid biopsy market, the ‘holy grail’ of cancer diagnostics. The company has developed technology that recently outperformed the gold standard in the field. Angle is hoping to raise £12.2M […]

October 5, 2017 - 3 minutesmins - By Alex Dale

Nobel Prize in Chemistry 2017 Richard Henderson Heptares Therapeutics

News and Trends 5 Oct 2017

British Biotech Founder Receives the Nobel Prize in Chemistry 2017

Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology to discover new medicines. This year’s Nobel Prize in Chemistry has been awarded to Jacques Dubochet, Joachim Frank and Richard Henderson for the development of cryo-electron microscopy. This technology, now widely used in structural biology labs, is considered a stepping […]

October 5, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Oct 2017

Drugs Can Now be Delivered to Cells On Demand with Light

Cells can be ‘hotwired’ to take up drugs or nanoparticles by endocytosis on demand according to research carried out in the UK. Researchers at Warwick Medical School have found a way to trigger endocytosis in cells. The research, which is published in The Journal of Cell Biology, uses the cell’s own proteins to initiate the endocytosis […]

October 2, 2017 - 3 minutesmins - By Alex Dale

News and Trends 28 Sep 2017

Everyone Wants a Piece of this Scottish Biotech’s AI

Evotec has doubled down on its investment in Exscientia: the German outfit just announced it has invested €15M to take a minority stake. Sanofi, GSK and Evotec have all jumped at the opportunity to work with Exscientia, a Scottish startup founded in 2012 and incubating in Dundee. Now, Evotec has gone beyond the initial immuno-oncology deal […]

September 28, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 28 Sep 2017

Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs

Nightstar has gone public on the American market with the aim of raising $75M for its gene-based retinal disease cures. Spun out from Oxford in 2013, Nightstar is developing and commercializing one-shot gene therapies for various eye diseases that could lead to blindness. This morning, it debuted on the Nasdaq with a projected $75M (£56M / €64M) […]

September 28, 2017 - 2 minutesmins - By Evelyn Warner

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us